Recombinant full-length human RIPK3 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Catalog No. R09-10G
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| R09-10G-05 | 5 ug | $226 | |
| R09-10G-10 | 10 ug | $325 | |
| R09-10G-BULK | BULK | Contact Us |
Overview:
RIPK3 is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases, which contains a C-terminal domain unique from other RIP family members. RIPK3 is predominantly localized to the cytoplasm, and specifically, are colocalized in the mitochondrion which can undergo nucleocytoplasmic shuttling dependent on novel nuclear localization and export signals (1). RIPK3 is a component of the tumor necrosis factor (TNF) receptor-I signaling complex, and can induce apoptosis and weakly activate the NF-kappaB transcription factor and caspase-8 prevents RIPK3-dependent necrosis without inducing apoptosis by functioning in a proteolytically active complex with CFLAR and that this complex is required for the protective function (2).
Gene Aliases:
RIP3
Genbank Number:
References:
1. Kasof, G. M.et.al: The RIP-like kinase, RIP3, induces apoptosis and NF-kappa-B nuclear translocation and localizes to mitochondria. FEBS Lett. 473: 285-291, 2000.
2. Oberst, A. et.al: Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471: 363-367, 2011.
Specific Activity:
Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet.
|
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
|
Storage, Stability and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
~96 kDa
Product Datasheets
Hou J
et al., Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
Cell Death & Disease June 2019 10.1038/s41419-019-1735-6
A Fauster et al., A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis Cell Death & Disease May 2015 10.1038/cddis.2015.130
Apoptosis/Autophagy, Cancer, Inflammation, JAK/STAT Pathway, JNK/SAPK Pathway, p38 Pathway, Ser/Thr Kinases
LRRK2, Active, L10-11G
RIPK2, Active, R08-11G
RIPK5, Active, R27-10G
RIPK2 (K47A), Unactive, R08-16G
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com